FindTrial
Sign In

A randomized controlled trial of the survival rate of patients with preoperative TACE after the surgery of the large resectable liver cancer

A randomized controlled trial of the survival rate of patients with preoperative TACE after the surgery of the large resectable liver cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-07000020
Enrollment
Unknown
Registered
2007-10-31
Start date
2001-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary hepatic carcinoma

Interventions

Phase I surgery group:Surgery operation
Phase II surgery group:TACE + surgery operation

Sponsors

Eastern liver and gall surgical hospital of The Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. patients with resectable primary hepatic carcinoma (Diameter >=5cm); 2. hepatic function: Child-A; 3. no metastasis out of the liver; 4. non apparent abnormality of the heart, lung, and kidney.

Exclusion criteria

Exclusion criteria: 1. patients with the small primary hepatic carcinoma (Diameter<5cm); 2. hepatic function: Child-B or Child-C; 3. have metastasis; 4. have organ diseases cannot tolerate the surgery.

Design outcomes

Primary

MeasureTime frame
Survival without tumour;Survival;—

Secondary

MeasureTime frame
Pathological indexes;Tumour resected rate;Liver function;—

Countries

China

Contacts

Public ContactWeiping Zhou
EHPHWP@126.com+86 021 25070792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026